Last reviewed · How we verify
NCT03043612
Ureteral Stent Study
NA trial testing Cook Sof-Flex® Double Pigtail Ureteral Stent coextruded with doxazosin in Urolithiasis in 56 participants. Completed in 30 June 2017.
16 June 2017
Quick facts
| Lead sponsor | Cook Group Incorporated |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | device feasibility |
| Enrollment | 56 |
| Start date | 10 June 2015 |
| Primary completion | 16 June 2017 |
| Estimated completion | 30 June 2017 |
| Sites | 1 location across Hong Kong |
Drugs / interventions tested
- Cook Sof-Flex® Double Pigtail Ureteral Stent coextruded with doxazosin
- Cook Sof-Flex® Double Pigtail Ureteral Stent
Conditions studied
- Urolithiasis — all drugs for Urolithiasis →
Sponsor
Cook Group Incorporated
Who can join
18 and older, any sex, with Urolithiasis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to evaluate the feasibility of the Cook Ureteral Stent to reduce post-stent placement pain and urinary symptoms in patients following ureteroscopy for urolithiasis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03043612
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Urolithiasis
Currently open trials in the same condition.
- NCT07378904 — Sterile Water Injection vs Morphine for Renal Colic · NA · active not recruiting
- NCT06989320 — Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Disease · NA · recruiting
- NCT06651294 — Efficacy of Neorenal Forte for the Complete Elimination of Residual Fragments · NA · recruiting
- NCT07514676 — Predictive Value of Preoperative Urine Culture for Postoperative Fever After FANS-RIRS When Surgery Proceeds Before Cult · active not recruiting
- NCT06158620 — Intra-nasal Ketorolac for Acute Ureteral Stent-associated Pain Following Ureteroscopy for Stone Disease · Phase 1, PHASE2 · recruiting
Other Cook Group Incorporated trials
Trials by the same sponsor.
- NCT03321266 — Retrospective Review of the Cook Biodesign® Fistula Plug to Treat Anorectal Fistulas · completed
- NCT02936622 — Paclitaxel-coated Peripheral Stents Used in the Treatment of Femoropopliteal Stenoses · NA · completed
- NCT02471781 — Zenith® TX2® Low Profile TAA Endovascular Graft · approved for marketing
- NCT02557659 — Zenith® Low Profile AAA Endovascular Graft · no longer available
- NCT02577562 — Zenith® Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Continued Access Study · approved for marketing
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03043612 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cook Group Incorporated
- Last refreshed: 2 July 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03043612.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing